Racial differences in renal arteriolar structure in children with minimal change nephropathy  by Rostand, Stephen G. et al.
Kidney International, Vol. 68 (2005), pp. 1154–1160
VASCULAR BIOLOGY – HEMODYNAMICS – HYPERTENSION
Racial differences in renal arteriolar structure in children with
minimal change nephropathy
STEPHEN G. ROSTAND, SARITA K. CROSS, KATHARINE A. KIRK, JEANNETTE Y. LEE,
ALEXANDER KUHLMANN, and KERSTIN AMANN
Nephrology Research and Training Center, Division of Nephrology, Department of Medicine, University of Alabama at
Birmingham, Birmingham, Alabama; Department of Biostatistics, University of Alabama at Birmingham, Birmingham, Alabama;
Comprehensive Cancer Center, The University of Alabama at Birmingham, Birmingham, Alabama; and Department of Pathology,
Friedrich-Alexander University Erlangen-Nu¨rnberg, Erlangen, Germany
Racial differences in renal arteriolar structure in children with
minimal change nephropathy.
Background. African Americans are at increased risk for hy-
pertension and chronic renal disease. Some data suggest this re-
sults from renal microvascular disease. The aim of this study was
to determine if renal vascular changes were more pronounced
in African Americans, were independent of blood pressure, and
occurred in early childhood
Methods. We performed morphometric analysis on small cor-
tical arteries and arterioles from 44 renal biopsies done in
African American and white children (mean age 8.4 ± SD
5.0 years) with minimal change nephropathy. Outer and inner
vessel diameters were measured and wall:lumen and wall:outer
diameter ratios (WT/OD) calculated. Clinical data on blood
pressure, steroid use, serum creatinine, gender, age, and pro-
teinuria were abstracted by chart review. A z score for systolic
and diastolic blood pressure was calculated. Follow-up clinical
data were available for 11 children. Data were compared using
analysis of covariance (ANCOVA) and t test for paired data.
Results. Lumen diameters of African Americans were 3.1 lm
(23%) smaller that those of white children (P = 0.024). Sim-
ilarly, their WT/OD was greater than in the whites, 0.31±0.03
vs. 0.28 ± 0.02 (P = 0.048). These changes were independent
of age, steroid use, systolic blood pressure and diastolic blood
pressure z scores. Follow-up data showed a rise in serum creati-
nine (>50%) in five patients, +1.42 ± 0.79 mg/dL (P = 0.016),
of whom four were African American. There was no change in
blood pressure.
Conclusion. The renal arterioles of African American chil-
dren with minimal change nephropathy exhibit significantly
smaller lumens and thicker walls than white children. The
changes occur very early in life and are independent of age,
blood pressure, and steroid use. Such changes may contribute
to the African American predisposition to chronic renal disease
and hypertension.
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African Americans have an increased prevalence of
hypertension and hypertension-associated renal disease
and faster rates of deterioration of renal function when
compared with whites [1–6]. The reasons for these in-
creased susceptibilities are complex but studies have sug-
gested a greater prevalence of microvascular disease in
blacks [7, 8], including renal microvascular disease. With
respect to the kidney, angiographic studies have demon-
strated attenuation of the renal vasculature in African
Americans compared to whites while others have shown
that African Americans also have greater renal vascu-
lar resistance, reduced renal blood flow, and impaired
renal blood flow autoregulation [9–11]. Together these
studies suggest that renal microvascular disease may con-
tribute significantly to the increased risk for hypertension
and renal disease in African Americans [12, 13]. More-
over, anatomic studies of renal cortical arterioles [14,
15] showing that African Americans, from young adult-
hood to older age, had more intimal fibroplasia and lu-
minal narrowing than whites also support this view and
a recent study of young adults, by Marcantoni et al [16]
has shown that, independent of blood pressure and age,
African Americans with hypertensive-induced chronic
kidney disease had worse renal vascular sclerosis than
whites. Narrowed renal arterioles have also been demon-
strated in a small number of children and are felt to be
precursors of hypertension and hypertension-associated
renal failure [15].
The previously cited studies have suggested an in-
creased susceptibility for renal microvascular disease in
African Americans [12, 13], that these changes may be
independent of blood pressure and may precede the on-
set of hypertension and progressive renal deterioration.
However, because some of the above-mentioned studies
were carried out in subjects who were already hyperten-
sive or who had advanced kidney disease [9, 16], it is dif-
ficult to know if the structural and functional changes
in the vasculature were related to hypertension or
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advanced renal disease. Moreover, the number of chil-
dren studied was too small to know if such racial
differences would be seen in a larger population of chil-
dren. To examine further the issue of increased African
American susceptibility to renal microvascular disease
we performed quantitative morphometric analyses of re-
nal cortical arterioles in kidney biopsies from children
with minimal change nephropathy in order to confirm
the racial differences in renal arteriolar structure and to
determine if such changes occur early in life as suggested
by Tracy et al [14, 15] and to determine whether these
changes are related to blood pressure.
METHODS
Study material
Percutaneous kidney biopsies from 54 children with
minimal change nephropathy performed between 1983
and 1991 were made available to us for review. Of these
10 were unusable because of inadequate tissue or because
there were insufficient patient data in the medical records.
Biopsies from children with minimal change nephropa-
thy were chosen for three reasons: (1) it is not ethically
possible to obtain renal tissue from apparently normal
subjects; (2) there was a paucity of autopsy material; and
(3) we thought minimal change nephropathy was the least
structurally altered tissue available by biopsy.
We studied 44 renal biopsies that contained a mean
of 24.7 ± 14.2 glomeruli/biopsy. We performed morpho-
metric measurements of 483 renal cortical arterioles in
the 44 biopsy specimens available for analysis (11.5 ±
SD 3.0 arterioles/biopsy) using an Olympus BX60 mi-
croscope and image analysis software (Analysis PRO,
SIS Co., Mu¨nster, Germany). Unless otherwise stated, all
measurements were made at a magnification of 400×. For
each vessel we measured the outer diameter (OD), ex-
cluding the adventitia, the inner diameter (lumen) (ID),
and the cross-sectional area. The thickness of the arterio-
lar wall (WT) was calculated: WT = (OD − ID)/2 as was
the ratio of arteriolar wall thickness to lumen diameter
(W/L) = WT/ID. To assess the relationship of wall thick-
ness to vessel size we calculated the ratio of wall thickness
to vessel cross-sectional diameter (WT/OD). A single in-
vestigator who was blinded to the clinical data did the
morphometry.
Clinical data
Clinical information regarding each subject was ob-
tained from a review of the subject’s medical record at
the Children’s Hospital, Birmingham, Alabama. The data
included on all patients were age at biopsy, race, gen-
der, and blood pressure within 1 week of biopsy, corti-
costeroid use, and proteinuria. All blood pressures were
determined oscillometrically in the pediatric nephrology
clinic. An investigator who was blinded to the biopsy re-
sults did data gathering.
Because there was a wide age range in the study pop-
ulation (6 months old to 17 years old) and since blood
pressure is known to increase with age, we adjusted the
systolic and diastolic blood pressure of each child for
age by creating a z score. This score compares the sub-
ject’s blood pressure with published age-related norma-
tive blood pressure data [17]. The z score is the fraction of
the standard deviation for age-related normative systolic
and diastolic blood pressure that is represented by the
systolic or diastolic blood pressure of each subject. Ap-
proval for the review of clinical records and pathology
specimens was obtained from the Institutional Review
Board for Human Research at the University of Alabama
at Birmingham.
Statistical analysis
The analysis of the structural parameters of renal arte-
rioles and clinical data was done by analysis of covariance
(ANCOVA). The covariates used were age at biopsy, cor-
ticosteroid use, and z systolic blood pressure, or z diastolic
blood pressure, race, gender, and the race-gender inter-
action. Analyses were performed on the common loga-
rithm transformed values of the original data in order to
(1) create more homogeneous within-cell variances and
(2) improve the adherence of the model residuals to the
normality assumption. A child was represented in this
analysis by the average of his/her log-transformed values
of his/her individual vessels.
Follow-up data were available for 11 patients and were
analyzed using the t test for paired data or chi-square test.
Data are expressed as the mean ± standard deviation
(SD) unless otherwise stated.
RESULTS
Minimal change subjects
The demographic and clinical characteristics of the
study population are shown in Table 1. There were 44
subjects of whom 20 were female and 24 male. There
were 16 African American and 28 whites. The mean age
of the total group was 8.4 ± 5.0 years. No significant age
differences for these parameters were seen between boys
and girls, between African American and white children,
or between race by gender subgroups. The mean z systolic
blood pressure for the entire group was 1.01 ± 1.39 and
no significant racial or gender differences were observed.
Fifty percent of patients were receiving corticosteroids at
the time of the biopsy. None of the subjects was receiving
antihypertensive therapy. The mean serum creatinine for
the group was 0.59 ± 0.3 mg/dL.
Table 2 shows the structural parameters of the renal
arterioles. The average OD of the all the arterioles was
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28.9 ± 7.2 lm while the mean ID (lumen) was 12.6 ±
2.0 lm. The mean WT was 8.2 ± 0.2.0 lm. The result-
ing mean W/L was 0.84 ± 0.28. Figures 1 and 2 show
examples of vascular structure. All structural parameters
were independent of z systolic blood pressure, age, race,
gender, race × gender, and steroid use except for ID
(lumen) that was significantly associated with race and
gender (Table 2). The ID (lumen) in African Ameri-
cans was significantly smaller than in whites (P = 0.0243)
and in girls as compared to boys (P = 0.0488). Analysis
of the race by gender subgroups revealed that African
American girls had significantly smaller lumens and
larger W/L than white boys (P = 0.005 and P = 0.02,
respectively) (Table 2). When similar analyses were done
using z diastolic blood pressure instead of z systolic
blood pressure no statistically significant associations
were found.
We examined the relationship between arterial and ar-
teriolar wall thickness and cross-sectional diameter thus
limiting the influence of vessel size. The ratio of WT/OD
was significantly greater in the African Americans than in
whites (0.31 ± 0.03 vs. 0.28 ± 0.02) (P = 0.048). As in the
previous analyses, this difference was independent of age,
gender, and steroid use, z systolic blood pressure and z
diastolic blood pressure. Unlike W/L, no race-by-gender
differences were observed for WT/OD.
Follow-up data
Paired data were available for 11 subjects, seven
African American four white, mean age 7.86 ± 5.3 years,
who were followed for a minimum of 9 months, 3.95 ±
2.5 years (Table 3). During this period, serum creatinine
increased from 0.6 ± 0.14 mg/dL at the time of biopsy
to 1.31 ± 0.77 mg/dL (difference = +0.7 ± 0.85 mg/dL)
(P = 0.02). Over this same time period, z systolic blood
pressure was not significantly changed. Although serum
creatinine rose significantly, the greatest change (>50%
increase), 0.52 ± 0.1 to 1.94 ± 0.73 mg/dL (P = 0.016)
occurred in five subjects, four of whom were African
American (group 1). The mean age of this sub-group was
5.5 ± 4.9 years. They had been followed 3.27 ± 2.2 years
(range 10 months to 5.2 years). No significant change in z
systolic blood pressure was noted, ± 0.32 ± 0.79. The re-
maining six subjects (three African American and three
white) (group 2) had no significant change in serum cre-
atinine or z systolic blood pressure over a similar period
of follow-up. While more African Americans were found
in group 1, no significant differences were noted between
groups 1 and 2 (v 2 = 1.06, P ≤ 1.0).
DISCUSSION
Our data show that renal arteriolar luminal diame-
ters were significantly narrower and WT/OD greater in
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Table 2. Structural parameters of renal arterioles of children with minimal change nephropathy
Black females Black males White females White males Black total White total Female total Male total All subjects
Variable (N = 10) (N = 6) (N = 10) (N = 18) (N = 16) (N = 28) (N = 20) (N = 24) (N = 44)
OD lm 27.1 ± 4.2 26.3 ± 5.2 26.3 ± 4.9 32.2 ± 9.0 26.8 ± 4.4 30.1 ± 8.2 26.7 ± 4.5 30.7 ± 8.5 28.9 ± 7.2
ID lm 10.5 ± 2.0a 10.9 ± 3.0 11.4 ± 3.1 15.0 ± 5.2 10.6 ± 2.3b 13.7 ± 4.8 10.9 ± 2.6c 13.9 ± 5.0 12.6 ± 4.3
Area lm2 1323 ± 751 1071 ± 473 970 ± 345 1467 ± 770 1231 ± 655 1289 ± 686 1148 ± 597 1368 ± 719 1268 ± 668
WT lm 8.3 ± 1.4 7.7 ± 2.3 7.5 ± 1.0 8.6 ± 2.5 8.1 ± 1.8 8.2 ± 2.1 7.9 ± 1.2 8.4 ± 2.4 8.2 ± 2.0
W/L 1.05 ± 0.34d11 0.87 ± 0.41 0.79 ± 0.15 0.74 ± 0.20 0.98 ± 0.37 0.76 ± 0.18 0.92 ± 0.29 0.77 ± 0.27 0.84 ± 0.28
WT/OD 0.32 ± 0.03 0.29 ± 0.05 0.29 ± 0.02 0.28 ± 0.03 0.31 ± 0.04e 0.28 ± 0.03 0.30 ± 03 0.28 ± 0.04 0.29 ± 0.03
Glomeruli 24.3 ± 12.6 22.8 ± 11.8 27.6 ± 19.8 23.9 ± 13.0 23.8 ± 12.0 25.3 ± 15.5 26.0 ± 16.3 23.7 ± 12.5 24.7 ± 14.2
number
Values are mean ± SD. Abbreviations are: OD, outer diameter; ID, inner diameter (lumen); area, cross-sectional area; WT, arteriolar wall thickness; W/L, wall to
lumen ratio; WT/OD, wall thickness to outer diameter ratio. Statistical analysis done by analysis of covariance (ANCOVA) on logarithm-transformed data. Covariance
adjustments were made for age at biopsy, race, gender, race by gender, steroid use, and systolic blood pressure z score.
aP = 0.005 (black females vs. white males); bP = 0.024 (black vs. white); cP = 0.048 (female vs. male); dP = 0.02 (black females vs. white males);
eP = 0.48 (black vs. white).
A B
Fig. 1. Comparison of small cortical arteries.
(A) Small cortical artery from a renal biopsy
of an African American girl age 10 years
old (Masson’s trichrome stain, 400× magni-
fication). Subject’s mean wall to lumen ratio
(W/L) = 1.74; mean wall thickness to outer di-
ameter ratio (WT/OD) = 0.37; systolic blood
pressure z score = 0.16. (B) Two small cortical
arteries from a renal biopsy from a white girl
age 4.5 years (Masson’s trichrome stain, 400×
magnification). Subject’s mean W/L = 1.06;
mean WT/OD = 0.31; systolic blood pressure
z score = 0.55.
A B
Fig. 2. Comparison of large cortical arteries.
(A)Large cortical artery from a renal biopsy
of an African American girl age 10 years old
(Masson’s trichrome stain, 200× magnifica-
tion). Subject’s mean wall to lumen ration
(W/L) = 1.74; mean wall thickness to outer di-
ameter ratio (WT/OD) = 0.37; systolic blood
pressure z score = 0.16. (B) Large cortical
artery from a renal biopsy from a white boy
age 7.6 years old (Masson’s trichrome stain,
200× magnification). Subject’s mean W/L =
0.79; mean WT/OD = 0.29; systolic blood
pressure z score = 0.2.
African American than Caucasian children and that these
changes occurred very early in life and were independent
of blood pressure. With the exception of WT/OD and
small ID (lumen), that were also found to be associated
with gender, largely because arteriolar lumens of African
American girls were significantly smaller than those of
white boys, none of the other structural parameters mea-
sured was associated with race, gender, blood pressure,
or steroid use. These racial differences in renovascular
structure in children are similar to blood pressure in-
dependent differences in renal vasculature described by
Marcantoni et al [16] for adult African Americans with
renal insufficiency due to hypertension. Our findings also
agree with the observations of Tracy et al [15] that such
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Table 3. Baseline and follow-up clinical data from eleven subjects with minimal change nephropathy
Serum Serum z Systolic z Systolic z Diastolic z Diastolic
Follow- up creatinine 1 creatinine 2 blood blood blood blood
Subjects Age years years mg/dL mg/dL pressure 1 pressure 2 pressure 1 pressure 2
Total (7 blacks and 4 whites) 7.8 ± 5.3 3.9 ± 2.5 0.6 ± 0.14 1.3 ± 0.7a 0.9 ± 1.06 1.2 ± 0.96 0.75 ± 1.3 1.0 ± 1.6
Group 1 (4 blacks and one white) 5.3 ± 4.9 3.3 ± 2.2 0.5 ± 0.11 1.9 ± 0.73b 1.2 ± 1.3 1.5 ± 1.0 0.72 ± 1.7 1.02 ± 1.7
Group 2 (3 blacks and 3 whites) 9.8 ± 5.2 4.5 ± 2.7 0.6 ± 0.14 0.78 ± 0.2 0.63 ± 0.78 1.0 ± 0.92 0.73 ± 0.85 0.73 ± 1.6
Values are mean ± SD. Group 1 are subjects with ≥50% increase is serum creatinine. Group 2 are subjects with <50% increase in serum creatinine. Serum creatinine1
and serum creatinine 2 are, respectively, baseline and follow-up serum creatinine. z systolic blood pressure 1, z systolic blood pressure 2, z diastolic blood pressure 1 and
z diastolic blood pressure 2 are, respectively, baseline and follow-up systolic and diastolic blood pressure z scores.
aP = 0.02 and bP = 0.016, Student t test for paired data.
lumen narrowing in African Americans may occur very
early in life, thus suggesting increased susceptibility for
renal microvascular disease in this population.
The racial differences in luminal diameter, though sta-
tistically significant, were small and might appear not
to be biologically important. Nevertheless, we estimated
that the 3.1 lm difference in ID (lumen) (23%) (Table 2)
observed between African American and white chil-
dren could produce approximately a 64% decrease in
renal blood flow and a 260% increase in renal vascu-
lar resistance for the African American children thus
demonstrating that small changes in ID (lumen) have the
potential for large hemodynamic effects. These estimates
are in keeping with the findings of Price et al [11] who
noted significantly lower renal plasma flow in healthy
young African Americans than in Caucasians. Thus, our
findings also might explain the altered renal hemody-
namics and tubuloglomerular feedback that have been
previously reported [10, 18]. Together with the previ-
ously mentioned studies [9–11, 14–16] our data support
the view that African Americans are at heightened risk
for developing renal microvascular disease and its atten-
dant hemo- and glomerulodynamic consequences early in
life.
Such changes may increase their risk for developing
hypertension and progressive renal deterioration. In this
regard, our follow-up data in a subset of 11 subjects re-
vealed a significant increase in serum creatinine and that
four of seven of the African American children (57%)
in the group showed greater than 50% increase in serum
creatinine compared to one of four white children (25%).
However, these data must be interpreted cautiously since
the sample size was very small and because no statisti-
cally significant racial differences with respect to changes
in serum creatinine were noted in the 11 children. More-
over, given the small size of a needle biopsy of the kid-
ney relative to the mass of the renal cortex, it is always
possible that the increase in serum creatinine may have
resulted from occult focal and segmental glomeruloscle-
rosis. Nevertheless, the results suggest a possible explana-
tion for the decrement in creatinine clearance noted over
time in African American children aged 7 to 13 years but
not in white children of similar age [19].
Other human and animal studies have also shown
an association between change in renal arteriolar struc-
ture and the subsequent development of hypertension
and renal disease. Katafuchi and Takebayashi [20] have
shown a close relationship in patients between intima-
media thickness of small arteries and arterioles and
parenchymal renal damage due to ischemia that pro-
duced deterioration of renal function, In animal studies,
Norreland et al [21] noted that narrowed distal renal ar-
teriolar lumens in 7-week-old spontaneously hyperten-
sive rats were associated with the later development of
increased blood pressure. Moreover, modest thickening
of the arteriolar media, increased renal vascular resis-
tance and glomerulosclerosis and ischemia were seen by
Sterzel et al [22] in Dahl S rats receiving low-salt or high
salt diets when compared with the Dahl R strain. Simi-
larly, Wang and Sanders [23] showed disordered vascu-
lar remodeling with proliferation of vascular sooth mus-
cles cells and subsequent tissue hypoxia in Dahl/Rapp S
rats.
The mechanisms underlying this apparent increased
susceptibility for microvascular disease in African Amer-
icans are uncertain and subject to much speculation.
Numerous racial differences in factors influencing mi-
crovascular growth, remodeling, and tone have been
described. These include intrinsic and/or acquired
endothelial dysfunction [24], and increased production
or responsiveness to growth factors. The possibility
that genetic alterations in growth factor production
are involved seems less certain since a genetic linkage
analysis reported by Freedman et al [25] did not demon-
strate a significant contribution of growth factor loci to
chronic kidney disease in African Americans. Neverthe-
less, there is still strong evidence that growth factors are
important contributors since transforming growth factor
beta 1 (TGF-b1) is shown to be overexpressed in African
Americans with end-stage renal disease (ESRD) [26, 27]
may produce vasoconstriction, increased vascular tone,
and hypertension [28], suggesting that the renal vascu-
lature in this population may be overly responsive to
growth factors or that the observed changes may be in
some way acquired. In this respect, African Americans
have been found to have potassium-deficient diets
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[29, 30] and altered calcium homeostasis [31–33] and such
alterations have also been shown to affect renal mi-
crovascular structure. In experimental studies Tobian et
al [34] have demonstrated that Dahl S rats fed potassium-
restricted diets developed significant renal arteriolar
wall thickening, luminal narrowing, and glomerular loss
that could be corrected by potassium supplementation.
African Americans are also at increased risk for vitamin
D deficiency and parathyroid hyperactivity as a conse-
quence of inefficient cutaneous photosynthesis of vitamin
D, reduced dietary calcium intake, and/or gastrointesti-
nal absorption, and increased risk for parathyroid activity
[31–33]. Alterations in these factors controlling calcium
homeostasis may either directly or indirectly alter vascu-
lar tone and vascular growth and remodeling [35], and
may be important contributors to the development of
hypertension and renal disease in African Americans
[36].
There may also be a role for the renin angiotensin
system (RAS) in affecting renovascular structure and
function seen in African Americans. Price et al [11]
recently reported that despite low circulating plasma
renin activity, African Americans had an increased ac-
tivation of the intrarenal RAS as manifested by an in-
creased renal vascular resistance and decreased renal
blood flow that corrected with the use of an angiotensin-
converting enzyme (ACE) inhibitor, demonstrating an
acute effect of ACE inhibitor on renovascular tone. An-
other study showed that longer-term blockade of the
RAS could produce significant increases of renal vas-
cular luminal diameter and decreases of wall thickness,
thereby affecting vascular resistance and stiffness [37].
This may, in part, explain how ACE inhibitors slow
the progression of renal disease in African Americans
[38].
The racial and gender differences in lumen diame-
ter that we noted largely resulted from the smaller ID
(lumen) and greater W/L seen in African American
girls. While no significant association between gender
and WT/OD was seen, African American girls still had
the greatest WT/OD. Since the African American girls
were slightly older, some may have undergone the on-
set of puberty, suggesting a possible role for estrogen
in gender differences in vascular structure we noted.
While estrogens are generally thought to protect against
hypertension and renal vascular damage [39, 40], some
experimental studies have shown them to adversely af-
fect the microvasculature [41, 42].
Last, there may also be a role for proteinuria in the
pathogenesis of renovascular change in our study. Al-
though all the children in our study were proteinuric, our
data suggest that the renal vasculature of African Ameri-
can children may be more susceptible than White children
to the effects of proteinuria on intima-media thickening
of renal arterioles [43].
CONCLUSION
We have found significantly smaller ID (lumen) and
an increased ratio of WT to cross-sectional diameter in
renal arterioles of African American children with min-
imal change nephropathy than in Caucasian children.
These changes were independent of systolic and diastolic
blood pressure, age, and steroid use. The mechanisms
underlying these racial differences are complex and our
study does not allow us to explain them. Our findings,
however, suggest that the renal vasculature of African
Americans may be hyperresponsive to factors affecting
vascular growth and tone. We believe the early develop-
ment and prolonged presence of small renal arteries and
arterioles with narrowed lumens and thickened walls may
contribute to alterations of renovascular and glomerular
dynamics, to renal ischemia, and ultimately to the devel-
opment of hypertension and progressive decline in renal
function. Thus these vascular alterations may be herald
signs of future renal damage.
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